Andere Sprachen BioNTech SE

Aktien

A2PSR2

US09075V1026

BNTX

Biotechnologie

Realtime-Estimate Cboe BZX Andere Börsenplätze 21:06:14 14.01.2025			% 5 Tage	% 1. Jan.
111,80 ^USD	-1,71 %		-11,55 %	-1,51 %

13.01.	Steigende Renditen bereiten Anlegern weiter Kopfschmerzen	DJ
13.01.	XETRA-SCHLUSS/Etwas leichter - DAX leidet unter hohen Renditen	DJ

Andere Sprachen

BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference	12:46
BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference	12:45
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	07.01.
A poor 2024 increases the odds of a brighter 2025	02.01.
BioNTech to Pay $1.3 Billion Settlement Fee for COVID-19 Vaccine Royalties Lawsuit	29.12.
Sector Update: Health Care Stocks Lower in Late Afternoon Trading	27.12.
Sector Update: Health Care Stocks Lower in Afternoon Trading	27.12.
BioNTech Announces Settlement With National Institutes of Health, University of Pennsylvania Over Royalty Claims	27.12.
European Equities Close Higher in Friday Trading; Auto Stocks Rally	27.12.
BioNTech to Pay Up to $1.26 Billion in Covid-19 Vaccine Settlements With NIH, Penn	27.12.
BioNTech : Outlook Therapeutics,UnitedHealth... les valeurs à suivre aujourd'hui à Wall Street -	27.12.
BioNTech Settles Lawsuits With US NIH, UPenn Over Covid Vaccine Royalties	27.12.
BioNTech: accord avec l'Université de Pennsylvanie sur les vaccins Covid-19	27.12.
BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties	27.12.
BioNTech : INFORMATION INCLUDED AS PART OF THIS FORM 6 K Form 6 K	27.12.
European Equities Traded in the US as American Depositary Receipts Tumble in Friday Trading; Down 4.6% for Week	20.12.
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	17.12.
BioNTech : INFORMATION INCLUDED AS PART OF THIS FORM 6 K Form 6 K	13.12.
BioNTech SE And its Partner OncoC4 Inc. Continue Enrollment In Phase 3 Trial For BNT316/ONC-392 After FDA Lifts Partial Hold	13.12.
ImmunoPrecise Antibodies Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025	11.12.
European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading	11.12.
BioNTech : SABCS 2025	10.12.
RTW Biotech Opportunities Ltd Announces Appointment of Baroness Nicola Blackwood as Senior Independent Non-Executive Director	10.12.
European Equities Traded in the US as American Depositary Tread Water in Friday Trading	06.12.
Duality Biologics and BioNTech Present Positive Interim Data for Investigational B7-H3 Antibody-Drug Conjugate BNT324/DB-1311 in Advanced Solid Tumors At the ESMO Asia Congress 2024	06.12.

Werden Sie Mitglied, um Zugang zu mehr Nachrichten zu erhalten.

100% kostenlose Registrierung

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

BioNTech SE: Abwartende Phase

Am 08. November 2024 um 10:43 Uhr

BIONTECH : Die Dinge laufen gut

Am 05. November 2024 um 08:30 Uhr